July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Aberrant expression of Long Intergenic Non-coding RNAs in the whole blood of patients with Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • Jacey Ma
    Aier School of Ophthalmology, Central South University, Guangzhou, China
  • Zekai Cui
    Key Laboratory for Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou , China
  • Bin Li
    Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • Yu Shi
    Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • Heping Xu
    Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom
  • Jiansu Chen
    Aier School of Ophthalmology, Central South University, Guangzhou, China
  • Shibo Tang
    Aier School of Ophthalmology, Central South University, Guangzhou, China
  • Footnotes
    Commercial Relationships   Jacey Ma, None; Zekai Cui, None; Bin Li, None; Yu Shi, None; Heping Xu, None; Jiansu Chen, None; Shibo Tang, None
  • Footnotes
    Support  Project supported by the National Science Fund for Distinguished Young Scholars of China (Grant No. 81500749 ).
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1436. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jacey Ma, Zekai Cui, Bin Li, Yu Shi, Heping Xu, Jiansu Chen, Shibo Tang; Aberrant expression of Long Intergenic Non-coding RNAs in the whole blood of patients with Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1436.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Proliferative diabetic retinopathy (DR) is a sight-threatening complication of diabetes worldwide. The molecular mechanism underlying the pathogenesis of DR is not fully understood. In this study, we presented a comparative microarray analysis of whole blood RNA from patients who have over 20 years type 2 diabetes (T2D) PDR and those without any signs of DR.

Methods : Eleven of T2D patients with over 20 years diabetes duration were enrolled into the study. The presence or absence of DR was confirmed by fundus photography and fluorescein angiography. Of the 12 of T2D patients, 6 had active proliferative DR (PDR) and 6 were absence of any signs of DR (non-DR). Total RNA was extracted from whole blood and processed for Affymetrix microarray analysis. Gene Ontology (GO) annotation was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources v6.8 (http://david.abcc.ncifcrf.gov).

Results : A total of 54613 genes were detected in both groups, among which 1210 genes were significantly altered in PDR compared with non-DR (≥2 folds, P<0.05). GO annotation showed that the altered genes are involved in signaling pathways regulating pluripotency of stem cells, neuroactive ligand-receptor interaction, and cytokine-cytokine receptor interaction. Besides, 389 long intergenic non-coding RNAs (LincRNAs) were identified, and 28 of them were significantly altered in PDR samples. Of the 28 LincRNAs, 16 were upregulated and 12, including LINC00624, LINC00606, and LINC00692 were downregulated in PDR patients.

Conclusions : LincRNAs are previously thought to be "dark matter" of the genome. Emerging evidence suggests that aberrant expressions of LincRNAs are associated with the development of diabetic associate cardiovascular dysfunctions. Our results suggest that LincRNAs may be critically involved in the development of PDR.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×